MedImmune

This is the limited version of the MedImmune company profile: Join LinkedIn or Sign In to see more information.

MedImmune, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of products for prevention and treatment in therapeutic areas of infectious diseases, inflammatory diseases, and cancer in the United States. The company markets three products: Synagis, a humanized monoclonal antibody for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in pediatric patients; Ethyol for the treatment of unwanted side effects of specific types of chemotherapies and radiotherapies that are used to treat cancer; and FluMist, a vaccine for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents. The company also provides NeuTrexin, a trimetrexate glucuronate for injection; and RespiGam. In addition, MedImmune has various products under development stages. The company’s customers include pharmaceutical wholesalers, distributors, and specialty distributors. MedImmune, Inc. has strategic alliances with Critical Therapeutics, Inc. and Micromet AG. The company was founded in 1987 under the name Molecular Vaccines, Inc. and changed its name to MedImmune, Inc. in 1990. MedImmune is headquartered in Gaithersburg, Maryland. As of June 5, 2007, MedImmune Inc. is a subsidiary of AstraZeneca PLC.

Your Connections to MedImmune

To see how you’re connected: Join Now or Sign In

New Hires and Recent Promotions at MedImmune

What’s this?

To see more new hires & promotions: Join Now or Sign In

Stock Information about MedImmune

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com Copyright © 2008 Capital IQ

This LinkedIn Company Profile was created by LinkedIn and is about MedImmune. This page is not endorsed by or affiliated with MedImmune. For questions regarding LinkedIn Company Profiles,

MedImmune (MEDI) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions